AGT and Parkinson disease: The deleterious effects of Ang II-AT1 receptor binding were further confirmed by studies showing the neuroprotective effects of AT1 receptor antagonists in animal models of PD (Grammatopoulos et al., 2007; Rey et al., 2007).